Cargando…
Overcoming Therapeutic Inertia to Reduce the Risk of COPD Exacerbations: Four Action Points for Healthcare Professionals
BACKGROUND: Therapeutic inertia, defined as failure to escalate or initiate adequate therapy when treatment goals are not met, contributes to poor management of COPD exacerbations. METHODS: A multidisciplinary panel of five expert clinicians actively managing COPD and representative of UK practice d...
Autores principales: | Singh, Dave, Holmes, Steve, Adams, Claire, Bafadhel, Mona, Hurst, John R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570921/ https://www.ncbi.nlm.nih.gov/pubmed/34754186 http://dx.doi.org/10.2147/COPD.S329316 |
Ejemplares similares
-
Treatment of patients with COPD and recurrent exacerbations: the role of infection and inflammation
por: Santos, Salud, et al.
Publicado: (2016) -
Is the GOLD guideline for diagnosing obstruction in COPD discriminatory in predicting severe future COPD-related exacerbations and death?
por: McDonnell, Melissa J., et al.
Publicado: (2021) -
The IMPACT of triple versus dual single-inhaler therapy on exacerbations of COPD
por: Dobler, Claudia C.
Publicado: (2018) -
Therapeutic Inertia in Prescribing Biologics for Patients with Moderate-to-Severe Asthma: Workshop Summary
por: Sico, Isabelle P, et al.
Publicado: (2021) -
Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations?
por: Adepoju, Victor A.
Publicado: (2019)